EDB-102

N/A

Report date: 2026/05/08 20:02:52

Base Information

Drug NameEDB-102
Drug Alias NameEDB-102EDB102
ClassificationCell and gene therapy > Gene therapy > Gene editing
Mechanisms of ActionEGFR L858R inhibitors
TargetsEGFR L858R
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesCancer Hospital Of Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesCancer Hospital Of Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A